Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: The role of hepatitis B, C or D?
Zvi Ackerman, Boontar Valinluck, John G. McHutchison, Allan G. Redeker, Sugantha Govindarajan – 1 September 1992 – Forty‐six patients with chronic hepatitis delta virus infection were followed between 6 and 116 mo (mean = 32.8 mo; median = 24 mo). Nineteen patients (41%) demonstrated clinical courses with episodes of biochemical reactivation (ALT levels ≥ 10 times baseline values [group A]). Twenty‐seven patients (59%) had stable clinical courses without biochemical reactivation (group B). Patients in group A were younger than those in group B (30.5 vs.